Gentocin® Solution
Veterinary medicine · U.S. Food and Drug Administration, Center for Veterinary Medicine · United States
-
Animal drug application
38292 -
Animal drug product ID
8
What the source publishes
- Holder
- Intervet, Inc.
- Active ingredients
- Gentamicin Sulfate
- Form
- Liquid (Solution)
- Routes
- Subcutaneous, Intramuscular
- Supply regime
- RX
Names this record is found by
Complete source data
{
"form": "Liquid (Solution)",
"name": "Gentocin® Solution",
"holder": "Intervet, Inc.",
"routes": [
"Subcutaneous",
"Intramuscular"
],
"smpcUrl": null,
"marketed": null,
"useDomain": "veterinary",
"leafletUrl": null,
"supplyRegime": "RX",
"nativeProduct": {
"routes": [
"Subcutaneous",
"Intramuscular"
],
"species": {
"Dogs:43": "Dog, No Use Class Stated Or Implied",
"Cats (Domestic):118": "Cat, No Use Class Stated Or Implied"
},
"sortOrder": 0,
"withdrawals": [],
"doseFormName": "Liquid (Solution)",
"applicationId": null,
"specifications": "Each milliliter of sterile aqueous solution contains the equivalent of either 5 or 50 milligrams of gentamicin.",
"proprietaryName": "Gentocin® Solution",
"proprietaryNameId": 8,
"statusDescription": "RX"
},
"nativeSummary": {
"noohDate": null,
"publishDate": "2016-06-01",
"sponsorName": "Intervet, Inc.",
"applicationId": 6,
"applicationType": "N",
"proprietaryName": "Gentocin® Solution\n",
"applicationNumber": 38292,
"activeIngredientName": "Gentamicin Sulfate\n",
"applicationStatusCode": "A",
"applicationStatusValue": null,
"voluntaryWithdrawalDate": null
},
"targetSpecies": [
{
"code": "43",
"label": "Dogs",
"native": {
"key": "Dogs:43",
"population": "Dog, No Use Class Stated Or Implied"
},
"sourceId": "us.fda.animal-drugs",
"population": "Dog, No Use Class Stated Or Implied",
"canonicalId": "dog",
"mappingStatus": "mapped",
"mappingVersion": 1
},
{
"code": "118",
"label": "Cats (Domestic)",
"native": {
"key": "Cats (Domestic):118",
"population": "Cat, No Use Class Stated Or Implied"
},
"sourceId": "us.fda.animal-drugs",
"population": "Cat, No Use Class Stated Or Implied",
"canonicalId": "cat",
"mappingStatus": "mapped",
"mappingVersion": 1
}
],
"informationUrl": "https://animaldrugsatfda.fda.gov/adafda/views/#/search",
"ingredientScope": "application-level; no product-specific composition inferred",
"nativePublishDate": "2016-06-01",
"sourceDisposition": "reviewed-veterinary-application-product",
"useDomainEvidence": {
"basis": "publisher-dataset-scope",
"field": "sourceId",
"value": "us.fda.animal-drugs",
"version": 1,
"sourceId": "us.fda.animal-drugs"
},
"withdrawalPeriods": [],
"patientEligibility": "not-assessed",
"nativeApplicationId": 6,
"targetSpeciesStatus": "reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"activeIngredientsText": "Gentamicin Sulfate\n",
"nativeApplicationType": "N",
"applicationIngredients": [
{
"activeIngredientName": "Gentamicin Sulfate",
"activeIngredientTolerance": "<p>A tolerance of 0.1 part per million is established for negligible residues of gentamicin sulfate in the uncooked edible tissues of chickens and turkeys. Tolerances are established for total residues of gentamicin in edible tissues of swine as follows: 0.1 part per million in muscle, 0.3 part per million in liver, and 0.4 part per million in fat and kidney. A tolerance of 0.1 part per million is established for negligible residues of gentamicin sulfate in the uncooked edible tissues of chickens and turkeys. Tolerances are established for total residues of gentamicin in edible tissues of swine as follows: 0.1 part per million in muscle, 0.3 part per million in liver, and 0.4 part per million in fat and kidney.</p>"
}
],
"nativeApplicationNumber": 38292,
"nativeProprietaryNameId": 8,
"restrictionObservations": [
{
"indicationText": "For the treatment of infections of urinary tract (cystitis, nephritis), respiratory tract (tonsillitis, pneumonia, tracheobronchitis), skin and soft tissue (pyodermatitis, wounds, lacerations, peritonitis).",
"limitationText": "If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on the order of a licensed veterinarian.",
"populationText": "Dogs"
},
{
"indicationText": "For the treatment of infections of urinary tract (cystitis, nephritis), respiratory tract (pneumonitis pneumonia, upper respiratory tract infections), skin and soft tissue (wounds, lacerations, peritonitis), and as supportive therapy for secondary bacterial infections associated with panleucopenia.",
"limitationText": "If response is not noted after 7 days, the antibiotic sensitivity of the infecting organism should be retested. Federal law restricts this drug to use by or on the order of a licensed veterinarian.",
"populationText": "Cats"
}
],
"withdrawalPeriodsStatus": "not-reported",
"publisherIdentityMeaning": "applicationId/proprietaryNameId are technical website keys; applicationNumber is a separate FDA application reference",
"nativeNoticeOfHearingDate": null,
"nativeApplicationStatusCode": "A",
"nativeVoluntaryWithdrawalDate": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.animal-drugs" \
--data-urlencode "id=us:fda:animaldrugs:6:8"